Skip to main content
. 2022 Nov 11;24(Suppl H):H48–H56. doi: 10.1093/eurheartjsupp/suac059

Table 2.

MACE and SAQ at follow-up

Follow-up time 0–6 months 6–12 months 12–24 months
Number of patients 266 247 193
MACE—n. (%) 31 (11.7) 16 (6.5) 26 (13.5)
SAQ < 70—n. (%) 50 (18.8) 51 (20.6) 42 (21.8)

MACE, major adverse cardiovascular events; SAQ, Seattle Angina Questionnaire.